Solural Pharma was in November 2023 acquired by Scantox, and is today Scantox Ballerup. The former Solural Pharma ApS is a Danish speciality pharma situated in the Copenhagen area of Denmark. The company has development capabilities on its own, or together with partners and CROs to develop new oral formulations, from concept idea until clinical proof of concept. The company’s formulation technology platform provides innovative oral products having unique benefits regarding efficacy, safety and convenience thereby meeting the needs by the patients, the doctors and the society for the treatment of important medical conditions. The company has strong expertises in all aspects of pharmaceutical development and uses this to offer consultancy support to solve CMC development, and project management needs as well as CRO/CMO expertise providing solutions for low soluble oral drugs. Website: http://scantox.com
